Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

A new study, however by the universities of Manchester, Nottingham, Edinburgh and Dundee, published in the BMJ, has found that antipsychotic drugs prescribed to dementia patients cause more ... light ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

A BMJ investigation found seven of the eight doctors appointed by the US Food & Drug Administration (FDA) to review donanemab ...

when treating patients with ... Drugs for Enlarged Prostate May Also Protect Against Dementia With Lewy Bodies June 19, 2024 — Certain drugs commonly used to treat enlarged prostate may also ...

A BMJ investigation found seven of the eight doctors appointed by the US Food & Drug Administration (FDA) to review donanemab ...

SGLT2 inhibitors and dulaglutide are associated with comparable risk for dementia; however, it is uncertain whether these findings generalize to newer GLP-1 RAs.

The findings were particularly pronounced in individuals with dementia, pointing to a possible vascular benefit of higher BP.

Among the adverse effects reported in the trial, infusion-related reactions were observed in 26.4% of patients in the ...

Using advanced artificial intelligence algorithms, scientists are hoping to identify brain wave patterns associated with the risk of dementia.